Investigating the effects of empagliflozin on myocardial metabolic and lipid profile in healthy and metabolic syndrome murine models following acute myocardial infarction

Back

ESC Premium Access

Investigating the effects of empagliflozin on myocardial metabolic and lipid profile in healthy and metabolic syndrome murine models following acute myocardial infarction

Session: Antidiabetic drugs for treatment of cardiovascular disease

Topic: Metabolism

Speaker: Professor I. Andreadou (Athens, GR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Ioanna Andreadou

National & Kapodistrian University of Athens, Athens (Greece)

4 presentations

0 follower

7 more presentations in this session

Human epicardial adipose tissue-derived factors promote atrial endothelial dysfunction: role of pro-inflammatory cytokines and AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway

Speaker: Doctor W. Fakih (Strasbourg, FR)

Takotsubo syndrome induced oxidative stress and endothelial dysfunction in left ventricle of rat model: association with NADPH oxidases/SGLT2 pro- oxidant pathway

Speaker: Miss T. Tatarcheh (Strasbourg, FR)

Semaglutide improves contractile function in isolated human atrium

Speaker: Doctor P. Hegner (Regensburg, DE)

Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study

Speaker: Doctor F. Sinha (Regensburg, DE)

Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.

Speaker: Doctor S. Eiras (Santiago de Compostela, ES)

Access the full session

Antidiabetic drugs for treatment of cardiovascular disease

Speakers: Professor I. Andreadou, Doctor W. Fakih, Miss T. Tatarcheh, Doctor P. Hegner, Doctor F. Sinha...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources